.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Stakeholder Summit

New Treatment Landscape in MS — Preventing Long Term Disability Through High Efficacy Treatments in Early MS

June 17th 2021

Neil Minkoff, MD; Maria Lopes, MD, MS; Nancy Ross, PharmD, BCACP, MSCS, CSP; Thomas Leist, MD; and Darin Okuda, MD explore opportunities for improving long-term patient outcomes in MS through earlier use of high efficacy therapies, including those of clinical and payer consideration.

COPD Stakeholder Summit: Utilizing Peak Inspiratory Flow Rates to Individualize Treatment and Improve Outcomes

February 5th 2021

Various stakeholders who play a role in the management of chronic obstructive pulmonary disease (COPD) explore various topics pertaining to the current treatment of COPD and discuss the adoption of measuring peak inspiratory flow rates into clinical practice.